April 15, 2013
Bernstein Liebhard LLP is investigating whether the Board of Directors of Life Technologies Corporation (“Life Technologies” or the “Company”) (NASDAQ: LIFE) breached its fiduciary duty to its shareholders in agreeing to sell Life Technologies to Thermo Fisher Scientific (NYSE: TMO).
Under the terms of the agreement, Life Technologies shareholders will receive $76.00 in cash per fully diluted common share they own. The investigation is focused on the potential unfairness of the price to Life Technologies shareholders and the process by which the Life Technologies Board of Directors considered and approved the transaction.
Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last ten years.